Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Statistics from DESeq2</p>

שמור ב:
מידע ביבליוגרפי
מחבר ראשי: Alyssa C. Flint (16676029) (author)
מחברים אחרים: Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
יצא לאור: 2025
נושאים:
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
_version_ 1849927632436592640
author Alyssa C. Flint (16676029)
author2 Dana K. Mitchell (16676032)
Steven P. Angus (15084264)
Abbi E. Smith (16676035)
Waylan Bessler (16676038)
Li Jiang (16676041)
Henry Mang (15293185)
Xiaohong Li (16676044)
Qingbo Lu (16676047)
Brooke Rodriguez (16676050)
George E. Sandusky (16676053)
Andi R. Masters (16676056)
Chi Zhang (15084270)
Pengtao Dang (16676059)
Jenna Koenig (16676062)
Gary L. Johnson (15081520)
Weihua Shen (16676065)
Jiangang Liu (15018711)
Amit Aggarwal (16610489)
Gregory P. Donoho (16676068)
Melinda D. Willard (16676071)
Shripad V. Bhagwat (16676074)
D. Wade Clapp (16676077)
Steven D. Rhodes (16676080)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Alyssa C. Flint (16676029)
Dana K. Mitchell (16676032)
Steven P. Angus (15084264)
Abbi E. Smith (16676035)
Waylan Bessler (16676038)
Li Jiang (16676041)
Henry Mang (15293185)
Xiaohong Li (16676044)
Qingbo Lu (16676047)
Brooke Rodriguez (16676050)
George E. Sandusky (16676053)
Andi R. Masters (16676056)
Chi Zhang (15084270)
Pengtao Dang (16676059)
Jenna Koenig (16676062)
Gary L. Johnson (15081520)
Weihua Shen (16676065)
Jiangang Liu (15018711)
Amit Aggarwal (16610489)
Gregory P. Donoho (16676068)
Melinda D. Willard (16676071)
Shripad V. Bhagwat (16676074)
D. Wade Clapp (16676077)
Steven D. Rhodes (16676080)
author_role author
dc.creator.none.fl_str_mv Alyssa C. Flint (16676029)
Dana K. Mitchell (16676032)
Steven P. Angus (15084264)
Abbi E. Smith (16676035)
Waylan Bessler (16676038)
Li Jiang (16676041)
Henry Mang (15293185)
Xiaohong Li (16676044)
Qingbo Lu (16676047)
Brooke Rodriguez (16676050)
George E. Sandusky (16676053)
Andi R. Masters (16676056)
Chi Zhang (15084270)
Pengtao Dang (16676059)
Jenna Koenig (16676062)
Gary L. Johnson (15081520)
Weihua Shen (16676065)
Jiangang Liu (15018711)
Amit Aggarwal (16610489)
Gregory P. Donoho (16676068)
Melinda D. Willard (16676071)
Shripad V. Bhagwat (16676074)
D. Wade Clapp (16676077)
Steven D. Rhodes (16676080)
dc.date.none.fl_str_mv 2025-11-25T13:24:23Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30708760
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Cell Cycle
CDKs and CDK inhibitors
Chemotherapy
Combination chemotherapy
Gene Technologies
High-throughput sequencing
Preclinical Models
Animal models of cancer
Proteomics
Rare Cancers
Translational Research
dc.title.none.fl_str_mv Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Statistics from DESeq2</p>
eu_rights_str_mv openAccess
id Manara_7732ff6e312405125d2246fc1d7b7b7c
identifier_str_mv 10.1158/1078-0432.30708760
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30708760
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C. Flint (16676029)Dana K. Mitchell (16676032)Steven P. Angus (15084264)Abbi E. Smith (16676035)Waylan Bessler (16676038)Li Jiang (16676041)Henry Mang (15293185)Xiaohong Li (16676044)Qingbo Lu (16676047)Brooke Rodriguez (16676050)George E. Sandusky (16676053)Andi R. Masters (16676056)Chi Zhang (15084270)Pengtao Dang (16676059)Jenna Koenig (16676062)Gary L. Johnson (15081520)Weihua Shen (16676065)Jiangang Liu (15018711)Amit Aggarwal (16610489)Gregory P. Donoho (16676068)Melinda D. Willard (16676071)Shripad V. Bhagwat (16676074)D. Wade Clapp (16676077)Steven D. Rhodes (16676080)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyCell CycleCDKs and CDK inhibitorsChemotherapyCombination chemotherapyGene TechnologiesHigh-throughput sequencingPreclinical ModelsAnimal models of cancerProteomicsRare CancersTranslational Research<p>Statistics from DESeq2</p>2025-11-25T13:24:23ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708760https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307087602025-11-25T13:24:23Z
spellingShingle Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Alyssa C. Flint (16676029)
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Cell Cycle
CDKs and CDK inhibitors
Chemotherapy
Combination chemotherapy
Gene Technologies
High-throughput sequencing
Preclinical Models
Animal models of cancer
Proteomics
Rare Cancers
Translational Research
status_str publishedVersion
title Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_fullStr Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full_unstemmed Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_short Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_sort Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
topic Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Cell Cycle
CDKs and CDK inhibitors
Chemotherapy
Combination chemotherapy
Gene Technologies
High-throughput sequencing
Preclinical Models
Animal models of cancer
Proteomics
Rare Cancers
Translational Research